Frequency of breast cancer subtypes among African American women in the AMBER consortium
Abstract Background Breast cancer subtype can be classified using standard clinical markers (estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2)), supplemented with additional markers. However, automated biomarker scoring and classification schemes...
Main Authors: | Emma H. Allott, Joseph Geradts, Stephanie M. Cohen, Thaer Khoury, Gary R. Zirpoli, Wiam Bshara, Warren Davis, Angela Omilian, Priya Nair, Rochelle P. Ondracek, Ting-Yuan David Cheng, C. Ryan Miller, Helena Hwang, Leigh B. Thorne, Siobhan O’Connor, Traci N. Bethea, Mary E. Bell, Zhiyuan Hu, Yan Li, Erin L. Kirk, Xuezheng Sun, Edward A. Ruiz-Narvaez, Charles M. Perou, Julie R. Palmer, Andrew F. Olshan, Christine B. Ambrosone, Melissa A. Troester |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Breast Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13058-018-0939-5 |
Similar Items
-
EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer
by: Steven Lehrer, et al.
Published: (2022-01-01) -
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
by: Tomás Pascual, et al.
Published: (2019-04-01) -
Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women
by: Yara Abdou, et al.
Published: (2020-06-01) -
Should a Multigene Signature be Used in all Luminal Early Breast Cancers
by: Nawale Hajjaji, et al.
Published: (2019-06-01) -
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
by: Arian Lundberg, et al.
Published: (2019-02-01)